APAC

Hepatitis B and C diagnostics market to grow by $3.02b through 2028

Thanks to the emergence of immunosensors for HBV and HCV detection.

Asia Pacific set for rapid growth in menstrual health apps

It is driven by rising smartphone use in countries like China, India, and Japan.

Maternity health insurance market to reach $269.3b by 2032

Its growth is fuelled by an increased adoption of life insurance services and strategic developments.

Autoimmune disease testing market to be valued at $12.1b by 2033

One growth driver includes the rising prevalence of autoimmune diseases.

Global surgical microscopes market to reach $1.4b by 2030

Thanks to an increased demand in various medical fields.

Patient engagement technology market to rise by $37.4b through 2028

The sector is pivoting towards healthcare digitisation.

Sepsis drug development remains challenged amidst high trial failures

Currently, there are 14 drugs in late-stage development across eight major markets.

Global respiratory diagnostics market to be valued at $9.8b by 2030

Its growth is fuelled by an increase in diseases, such as asthma, COPD, and lung infections.

What factors fuel home blood testing devices market?

One key driver is the integration of artificial intelligence.

Femtech devices market to rise at 12.93% CAGR through 2028

Its expansion is attributed to the increasing rate of infertility and obesity-related cases in women.

Here’s what’s driving the APAC vascular stents market

One key factor is healthcare infrastructure advancements.

Global gamification healthcare app market to reach $4.48b by 2024

It is driven by increasing chronic diseases such as cardiovascular conditions, cancer, obesity, and diabetes.

Global knee replacement market to grow at 3.16% CAGR until 2033

Advancements, such as nanotechnology and kinematic alignment, are driving its expansion.

Human immunoglobulin market to surge by $9.7b through 2028

One key driver is the rising demand for treatments in hospitals and homecare settings.

Global breathing circuits market to hit $2.16b by 2029

Its growth is attributed to an increase in surgical procedures and a rise in chronic diseases.

Short-acting insulin market to cross $9b by 2030

Key drivers include technological advancements and evolving healthcare policies.